CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 437622-437754 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/867ebb2be2d466bcb35e5a7319708eaff39c4799","sourcedb":"CORD-19","sourceid":"867ebb2be2d466bcb35e5a7319708eaff39c4799","text":"We try to understand the molecular epidemiology of drugresistance associate variants (RAVs) in treatment-naïve HCVinfected patients.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T4","span":{"begin":0,"end":132},"obj":"Sentence"}],"attributes":[{"subj":"T4","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"T6768","span":{"begin":0,"end":132},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T6768","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T941","span":{"begin":51,"end":65},"obj":"Phenotype"}],"attributes":[{"id":"A941","pred":"hp_id","subj":"T941","obj":"http://purl.obolibrary.org/obo/HP_0020174"},{"subj":"T941","pred":"source","obj":"CORD-19-PD-HP"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93eca0","default":true},{"id":"CORD-19-Sentences","color":"#ec939f"},{"id":"CORD-19-PD-HP","color":"#93b9ec"}]}]}}